Table 1. Clinical characteristics, RAD 51 status and treatment response of patients.
Trial no. | Stage | HPV status | Smoking status (pack years) | Prognostic group | Difference in RAD51 foci pre- and post-IC (%) | RAD 51 status | Treatment response |
---|---|---|---|---|---|---|---|
1002 | T2N2B | −ve | 30 | Poor | 31 | Positive | CR |
1003 | T4N2B | +ve | 20 | Intermediate | 25 | Positive | CR |
1004 | T4N2B | −ve | 40 | Poor | 7 | Negative | PR |
1005 | T2N2B | −ve | 20 | Poor | 3 | Negative | PR |
1006 | T2N2B | +ve | Never | Good | 62 | Positive | CR |
1007 | T2N1 | +ve | Never | Good | 44 | Positive | CR |
1008 | T3N2B | +ve | 30 | Intermediate | 71 | Positive | CR |
1009 | T3N0 | +ve | 15 | Good | 74 | Positive | CR |
1010 | T4N2C | +ve | 30 | Intermediate | 27 | Positive | CR |
1011 | T3N2B | +ve | 30 | Intermediate | 72 | Positive | CR |
1013 | T4N2B | −ve | 40 | Poor | 3 | Negative | PR |
1014 | T2N2B | −ve | 40 | Poor | 27 | Positive | CR |
1015 | T3N2B | +ve | Never | Good | 57 | Positive | CR |
Abbreviations: CR=complete response; HPV=human papilloma virus; PR=partial response.